Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease

Published:2023-06-05 Issue:7 Volume:64 Page:9
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Xie Yanyan¹,Pan Yuan¹,Chen Qian¹,Chen Yuxi¹,Chen Guanyu¹,Wang Mei²,Zeng Peng²,Li Zhuang¹,Li Zuoyi¹,Wang Sha³⁴⁵,Yang Huasheng¹,Liang Dan¹

Affiliation:

1. Department of Ocular Immunology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China

2. Department of Ophthalmology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China

3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China

4. Eye Center of Xiangya Hospital, Central South University, Changsha, China

5. Hunan Key Laboratory of Ophthalmology, Changsha, China

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Reference51 articles.

1. Pathogenesis of Graves ophthalmopathy: implications for prediction, prevention, and treatment;Garrity;Am J Ophthalmol,2006

2. Rituximab for thyroid-associated ophthalmopathy;Kang;Cochrane Database Syst Rev,2022

3. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy;Wiersinga;Lancet Diabetes Endocrinol,2017

4. Advances in the pharmacological treatment of Graves' orbitopathy;Ruchala;Expert Rev Clin Pharmacol,2016

5. Surgical orbital decompression for thyroid eye disease;Boboridis;Cochrane Database Syst Rev,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease;Eye and Vision;2024-09-06

2. Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment;Biomaterials Research;2024-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3